This complements information on medicines published on EMA's website, which only includes medicines EMA evaluates. For more information on the different medicine authorisation routes in the EU, see Please note that the information in these national registers may not be available in English. For delivery address, see: How to find us EMA is in the process of making appropriate changes to this website.

EMA is in the process of making appropriate changes to this website. If the site still contains content that does not yet reflect the withdrawal of the UK from the EU, this is unintentional and will be addressed.

If the site still contains content that does not yet reflect the withdrawal of the UK from the EU, this is unintentional and will be addressed. European Medicines Agency's list of European experts The European Medicines Agency (EMA) maintains a public list containing details on all European experts who can be involved in the Agency's work. For help on how to get the results you want, see our Apply European public assessment reports (EPAR) filter Apply Periodic safety update report single assessments filter Apply Direct healthcare professional communication filter Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2020 Eleven new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended eleven medicines for approval at its July 2020 meeting, including a medicine for use in countries outside the European Union. National registers of authorised medicines. The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State.

European Medicines Agency - The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. European Medicines Agency Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands. Tel: +31 (0)88 781 6000. The European Medicines …

The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. The European Medicines Agency (EMA) provides guidance and templates to provide marketing authorisation applicants with practical advice on how to draw up the product information for human medicines, which includes the summary of product characteristics, labelling and package leaflet.EMA's guidance explains the content that should be included in these documents, as well as standard …